Antares Pharma: 3Q Earnings Snapshot

November 6, 2018

EWING, N.J. (AP) _ Antares Pharma Inc. (ATRS) on Tuesday reported a loss of $1.9 million in its third quarter.

The Ewing, New Jersey-based company said it had a loss of 1 cent per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.

The drugmaker posted revenue of $17.9 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $15.1 million.

The company’s shares closed at $3.49. A year ago, they were trading at $1.88.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRS at https://www.zacks.com/ap/ATRS

Update hourly